Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Can the blood-transmitted hepatitis problem be solved?

Annals of the New York Academy of Sciences

|January 20, 1975

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Methodology Used in DNA-Based Prophylactic and Therapeutic Immunization Against Hepatitis B Virus in Chimpanzees.

Methods in molecular medicine·2011

Same author

Development of the International Consortium for Blood Safety (ICBS) HCV panels.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2008

Same author

Schistosoma infection inhibits cellular immune responses to core HCV peptides.

Parasite immunology·2005

Same author

Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections.

Journal of viral hepatitis·2004

Same author

Perspectives on prophylactic and therapeutic immunization against hepatitis B and C viruses.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2002

Same author

Human milk contains detectable levels of immunoreactive leptin.

Advances in experimental medicine and biology·2002

Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026

Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026

Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026

Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026

Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026

Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026

See all related articles

Preventing blood-transmitted hepatitis requires avoiding high-risk donors and enhancing screening. Current hepatitis B virus (HBV) screening is insufficient, necessitating tests for other viruses and improved donor tracking for safer blood transfusions.

Area of Science:

Hepatology
Transfusion Medicine
Infectious Diseases

Background:

Blood-transmitted hepatitis remains a significant public health concern.
Current screening methods for hepatitis B virus (HBV) are not fully effective in eliminating all infectious blood donations.
Paid commercial donors represent a higher risk population compared to volunteer donors.

Purpose of the Study:

To evaluate the effectiveness of current strategies for preventing blood-transmitted hepatitis.
To identify limitations in existing screening methods for hepatitis B.
To explore potential improvements in blood safety measures.

Main Methods:

Review of existing approaches for hepatitis prevention in blood donations.
Analysis of the efficacy of hepatitis B antigen screening.

Related Experiment Videos

Discussion of limitations in current assays and potential alternative detection methods.

Main Results:

Avoidance of high-risk donor populations is the most effective prevention strategy.
Hepatitis B antigen screening, while useful, fails to detect a significant portion of infectious blood.
The existence of non-hepatitis B viruses contributes to blood-transmitted hepatitis, and tests for these are needed.

Conclusions:

Enhanced screening methods, including testing for Core antibody and investigational approaches, are necessary.
Development of tests for non-HBV agents is crucial for comprehensive blood safety.
Improved donor surveillance and reporting systems can further reduce hepatitis transmission risk.